References

ssmu

Бюллетень сибирской медицины

Bulletin of Siberian Medicine

1682-03631819-3684

Siberian State Medical University, the Ministry of Healthcare of the Russian Federation

10.20538/1682-0363-2024-2-114-122

ssmu-5668

Research Article

ОБЗОРЫ И ЛЕКЦИИ

REVIEW AND LECTURES

Синдром старческой астении и его особенности при болезни Паркинсона

Syndrome frailty and his features in Parkinson’s disease

https://orcid.org/0000-0001-8659-9832

Гусева

О. В.

Guseva

O. V.

Гусева Ольга Владимировна – канд. мед. наук, доцент, кафедра госпитальной терапии с курсом реабилитации, физиотерапии и спортивной медицин; врач лечебной физкультуры, отделение физиотерапии

634050, Томск, Московский тракт, 2

2, Moscow Тrakt, Tomsk, 634050

gusolvl@gmail.com

Сибирский государственный медицинский университет (СибГМУ)РоссияSiberian State Medical UniversityRussian Federation

2024

10072024

232114122

2024

Гусева О.В.

Guseva O.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://bulletin.ssmu.ru/jour/article/view/5668

Синдром старческой астении распространен во всем мире, и его появление связано с увеличением продолжительности жизни. В лекции показаны мультифакторность формирования синдрома: изменения физического здоровья, социальные и психологические факторы, а также гендерные особенности и влияние возраста. Классическая диагностика синдрома состоит в оценке физической слабости по фенотипу Фрайд. Современный взгляд на проблему дополняет диагностику индексами слабости для характеристики мультифакторности развития и применением цифровых носимых технологий для длительного мониторирования функциональных показателей пациента. Дано развернутое обоснование влияния коморбидности на развитие старческой астении. Особенностью синдрома старческой астении при болезни Паркинсона является трудность его диагностики при возможно высокой распространенности. Исследования старческой астении при болезни Паркинсона малочисленны, вероятно, из-за схожести симптомов болезни и синдрома. Определены возможные риски возникновения старческой астении при болезни Паркинсона: влияние различных форм болезни Паркинсона, пола, когнитивных и функциональных нарушений, полипрагмазии, дозы леводопы. Показана роль комплексной мультидисциплинарной реабилитации и самостоятельной физической активности при сочетании болезни Паркинсона и синдрома старческой астении.

Syndrome frailty is widespread all over the world and its appearance is associated with an increase in life expectancy. The lecture shows the multifactorial nature of the syndrome: changes in physical health, social and psychological factors, gender characteristics and age. The classic diagnosis of the syndrome consists in assessing physical weakness according to the Fried phenotype. The modern view of the problem complements the diagnosis with indices of weakness to characterize the multifactorial development and the use of digital wearable technologies for long-term monitoring of the patient’s functional parameters.The lecture provides a detailed justification of the effect of comorbidity on the development of syndrome frailty. The syndrome frailty is difficult diagnosed in Parkinson’s disease, because it has high prevalence in these. Studies of syndrome frailty in Parkinson’s disease are few, probably due to the similarity of the symptoms of the disease and the syndrome. The lecture identifies the possible risks of syndrome frailty in Parkinson’s disease: the influence of various forms of Parkinson’s disease, gender, cognitive and functional disorders, polypharmacy, levodopa doses. The role of multidisciplinary rehabilitation’s team and independent physical activity in the combination of Parkinson’s disease and syndrome frailty is shown.

синдром старческой астениидиагностикакоморбидностьболезнь Паркинсона

syndrome frailtydiagnosiscomorbidityParkinson’s disease

References1

Chen X., Giles J., Yao Y., Yip W., Meng Q., Berkman L. et al. The path to healthy ageing in China: a Peking University-Lancet Commission. Lancet. 2022;400(10367):1967–2006. DOI: 10.1016/S0140-6736(22)01546-X.

Melo Filho J., Moreira N.B., Vojciechowski A.S., Biesek S., Bento P.C.B., Gomes A.R.S. Frailty prevalence and related factors in older adults from southern Brazil: A cross-sectional observational study. Clinics. 2020;75:e1694. DOI: 10.6061/clinics/2020/e1694.

Palermo S., Stanziano M., Nigri A., Civilotti C., Celeghin A. Parkinson’s disease, SARS-CoV-2, and frailty: is there a vicious cycle related to hypovitaminosis D? Brain Sciences. 2023;13:528. DOI: 10.3390/brainsci13040528.

Kaczorowska A., Szwamel K., Fortuna M., Mroczek A., Lepsy E., Katan A. Assessment of physical fitness and risk factors for the occurrence of the frailty syndrome among social welfare homes’ residents over 60 years of age in Poland. Intl. J. Environl. Res. Public Health. 2022;19:7449. DOI: 10.3390/ijerph19127449.

Boissonneault M., Rios P. Changes in healthy and unhealthy working-life expectancy over the period 2002–17: a population-based study in people aged 51–65 years in 14 OECD countries. The Lancet Healthy Longevity. 2021;2(10):e629–e638. DOI: 10.1016/s2666-7568(21)00202-6.

Nguyen T.T.H., Nguyen A.T., Vu T.-H.T., Dau N.T., Nguyen P.Q., Nguyen T.X. et al. Association of frailty status and functional disability among community-dwelling people aged 80 and older in Vietnam. BioMed Res. Int. 2021;e7109452:1–6. DOI: 10.1155/2021/7109452.

Ahrenfeldt L.J., Möller S., Thinggaard M., Christensen K., Lindahl-Jacobsen R. Sex differences in comorbidity and frailty in Europe. Int. J. Public Health. 2019;64(7):1025–1036. DOI: 10.1007/s00038-019-01270-9.

Sousa-Fraguas M.C., Rodríguez-Fuentes G., Conejo N.N. Frailty and cognitive impairment in Parkinson’s disease: a systematic review. J. Neur. Sci. 2022;43(12):6693–6706. DOI: 10.1007/s10072-022-06347-7.

Salaffi F., De Angelis R., Farah S., Carotti M., Di Carlo M. Frailty as a novel predictor of achieving comprehensive disease control (CDC) in rheumatoid arthritis. Clin. Rheumatol. 2021;40:4869–4877. DOI: 10.1007/s10067-021-05744-1.

Clegg A., Young J., Iliffe S., Rikker M.O., Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–762. DOI: 10.1016/s0140-6736(12)62167-9.

Lewis l. How can identifying and grading frailty support older people in acute and community settings? Nurs. Older People. 2020;32(6):e1271. DOI: 10.7748/nop.2020.e1271.

Park C., Ko F.C. The Science of frailty: sex differences. Clin. Geriatr. Medi. 2021;37(4):625–638. DOI: 10.1016/j.cger.2021.05.008.

Roland K., Cornett K., Theou O., Jakobi J., Jones G. Physical activity across frailty phenotypes in females with Parkinson’s disease. J. Aging Res. 2012;e468156:1–8. DOI: 10.1155/2012/468156.

Ozer F., Akin S., Gultekin M., Erturkzararsiz G., Soylu A. Frailty in patients with Parkinson’s disease: associations with disability and Timed Up and Go. Arch. Neuropsychiatry. 2019;58:206–212. DOI: 10.29399/npa.23444.

Bartoli M., Palermo S., Cipriani G., Amanzio M. A possible association between executive dysfunction and frailty in patients with neurocognitive disorders. Front. Psychol. 2020;11:e554307. DOI: 10.3389/fpsyg.2020.554307.

Panhwar Y., Naghdy F., Naghdy G., Stirling D., Potter J. Assessment of frailty: a survey of quantitative and clinical methods. BMC Biomedical Engineering. 2019:1(1):1–20. DOI: 10.1186/s42490-019-0007-y.

Cobo A., Villalba-Mora E., Pérez-Rodríguez R., Ferre X., Rodríguez-Mañas L. Unobtrusive sensors for the assessment of older adult’s frailty: A Scoping review. Sensors. 2021;21(9):2983. DOI: 10.3390/s21092983.

Kumar D., Toosizadeh N., Mohler J., Ehsani H., Mannier C., Laksari K. Sensor-based characterization of daily walking: a new paradigm in pre-frailty/frailty assessment. BMC Geriatr. 2020;20(1):164. DOI: 10.1186/s12877-020-01572-1.

Pernas F., Carrasco-Ribelles L., Abellana R., Roso-Llorach A., Cegri F., Reyes C., Violán C. Validation of an electronic frailty index with electronic health records: eFRAGICAP index. BMC Geriatric. 2022;22:404. DOI: 10.21203/rs.3.rs-1368757/v1.

Zahir M., Wang C., Gardea M., Nguyen H., Shahbazi M., Sharafkhaneh A., Ruiz I.T. et al. Remote physical monitoring – the application of deep learning-based pimage processing in tele-health. IEEE Access. 2020;8:219391–219399. DOI: 10.1109/access.2020.3042451.

Ma L., Chan P. Understanding the physiological links between physical frailty and cognitive decline. Aging Dis. 2020;11(2):405–418. DOI: 10.14336/AD.2019.0521.

Rahman M.M., Mim S.A., Islam M.R., Parvez A., Islam F., Uddin M.B. et al. Exploring the recent trends in management of dementia and frailty: focus on diagnosis and treatment. Curr. Med. Chem. 2022;29(32):5289–5314. DOI: 10.2174/0929867329666220408102051.

Peng S., Zhou J., Xiong S., Liu X., Pei M., Wang Y. et al. Construction and validation of cognitive frailty risk prediction model for elderly patients with multimorbidity in Chinese community based on non-traditional factors. BMC Psychiatry. 2023;23:266. DOI: 10.1186/s12888-023-04736-6.

Tse M.M.Y., Kwan R.Y.C., Ho S.S.M., Davidson P.M.D., Cheng P.P.P., Yeung S.S.Y. Frailty is associated with pain and cognitive function in older people in post-acute care settings. Geriatr. Nurs. 2020;41(5):530–535. DOI: 10.1016/j.gerinurse.2019.04.001.

Park J., Kim W.J. Potential imaging biomarkers of cognitive frailty. Annals of Geriatric Medicine and Research. 2023;27(1):3–8. DOI: 10.4235/agmr.22.014137.

Kocyigit S., Soysal P., Bulut E., Aydin E., Dokuzlar O. What is the relationship between frailty and orthostatic hypotension in older adults? J. Geriatr. Cardiol. 2019;16:272–279. DOI: 10.11909/j.issn.1671-5411.2019.03.005.

Mol A., Slangen R.L.N., Trappenburg M.C., Reijnierse E.M., van Wezel R.J.A., Meskers C.G.M. et al. Blood pressure drop rate after standing up is associated with frailty and number of falls in geriatric outpatients. J. Am. Heart Ass. 2020;9(7):014688. DOI: 10.1161/jaha.119.014688.

Ardolino I., Franchi C., Nobili A., Mannucci P.M., Corli O. Pain and frailty in hospitalized older adults. Pain Therap. 2020;9:727–740. DOI: 10.1007/s 40122-020-00202-3.

Collard R.M., Comijs H.C., Naarding P., Penninx B.W., Milaneschi Y., Ferrucci L. et al. Frailty as a predictor of the incidence and course of depressed mood. J. Am. Med. Directors Ass. 2015;16(6):509–514. DOI: 10.1016/j.jamda.2015.01.088.

Oyon J., Serra-Prat M., Ferrer M., Linares A., Pastor N., Limón E. et al. Psychosocial factors associated with frailty in the community-dwelling aged population with depression. A cross-sectional study. Atención Primaria. 2021;53(5):e102048. DOI: 10.1016/j.aprim.2021.102048.

Atkins J., Jylhävä J., Pedersen N.L., Magnusson P.K., Lu Y., Wang Y. et al. A genome‐wide association study of the frailty index highlights brain pathways in ageing. Aging Cell. 2021;20(9):e13459. DOI: 10.1111/acel.13459.

Sathyan S., Barzilai N., Atzmon G., Milman S., Ayers E., Verghese J. Genetic insights into frailty: association of 9p21-23 locus with frailty. Front. in Med. 2018;5:e105. DOI: 10.3389/fmed.2018.00105.

McMillan J.M., Michalchuk Q., Goodarzi Z. Frailty in Parkinson’s disease: a systematic review and meta-analysis. Clin. Park & Related Disord. 2021;4:e100095. DOI: 10.1016/j.prdoa.2021.100095.

Tenison E., Henderson E.J. Multimorbidity and frailty: tackling complexity in Parkinson’s disease. J. Parkinson’s Dis. 2020;10(s1):85–91. DOI: 10.3233/jpd-202105.

Abraham D.S., Nguyen T.PP., Willis A.W. Claims‐based frailty and outcomes: applying an aging measure to older adults with Parkinson’s disease. Mov. Disord. 2021;36(8):1871–1878. DOI: 10.1002/mds.28561.

Wang C.-K., Chen H.-L., Lu C.-H., Chen M.-H., Chiang P.-L., Cheb Y.-S. et al. Altered body composition of psoas and thigh muscles in relation to frailty and severity of Parkinson’s disease. Inter. J. Environ Res. Pub. Health. 2019;16(19):e3667. DOI: 3390/ijerph16193667.

Jiménez-Cebrián A.M., Becerro-de-Bengoa-Vallejo R., Losa-Iglesias M.E., de Labra C., Calvo-Lobo C., Palomo-López P. et al. Kinesiophobia levels in patients with Parkinson’s disease: a case-control investigation. Inter. J. Environ Res. Pub. Health. 2021;18(9):e4791. DOI: 10.3390/ijerph18094791.

Figueroa C.A., Rosen C.J. Parkinson’s disease and osteoporosis: basic and clinical implications. Expert Rev. Endocrinol. Metab. 2020;15(3):185–193. DOI: 10.1080/17446651.2020.1756772.

Lin W.-C., Huang Y.-C., Leong C.-P., Chen M.-H., Chen H.-L., Tsai N.-W. et al. Associations between cognitive functions and physical frailty in patients with Parkinson’s disease. Front. Aging Neurosci. 2019;11:283. DOI: 10.3389/fnagi.2019.00283.

Taguchi C.K., de Lemos Menezes P., Melo A.C.S., de Santana L.S., Conceição W.R.S., de Souza G.F. et al. Frailty syndrome and risks for falling in the elderly community. Codas. 2022;34(6):e20210025. DOI: 10.1590/2317-1782/20212021 025en.

Baba Y., Putzke J.D., Whaley N.R., Wszolek Z.K., Uitt R.J. Gender and the Parkinson’s disease phenotype. J. Neurol. 2005;252(10):1201–1205. DOI: 10.1007/s00415-005-0835-7.

Hrytsuliak B., Ostapiak Z., Polataiko Y., Herych R., Lisovskyi B., Lapkovskyi E. et al. Dynamics of balance indicators, activities of daily living, and quality of life of elderly suffering from Parkinson’s disease and frailty after proximal humerus fracture following physiotherapeutic functional training. J. Med. Life. 2022;15(1):98–103. DOI: 10.25122/jml-2021-0386.

Yokote A., Hayashi Y., Yanamoto S., Fujioka S., Higa K., Tsuboi Y. Leg muscle strength correlates with gait performance in advanced Parkinson disease. Int. Med. 2022;61(5):633–638. DOI: 10.2169/internalmedicine.7646-21.

Álvarez-Bustos A., Rodríguez-Sánchez B., Carnicero-Carreño J.A., Sepúlveda-Loyola W., Garcia-Garcia F.J., Rodríguez-Mañas L. Healthcare cost expenditures associated to frailty and sarcopenia. BMC Geriatr. 2022;(22):747. DOI: 10.1186/s12877-022-03439-z.

Cohen C.J., Benyaminov R., Rahman M., Ngu D., Reinhardt M. Frailty. Med. Clin. North Am. 2023;107(1);183–197. DOI: 10.1016/j.mcna.2022.04.006.

Spiers G.F., Kunonga T.P., Hall A., Beyer F., Boulton E., Parker S. et al. Measuring frailty in younger populations: a rapid review of evidence. BMJ. Open. 2021;11:e047051. DOI: 10.1136/bmjopen-2020-047051.

The authors declare that there are no conflicts of interest present.